Alamar Biosciences, Inc. (California) (ALMR)
30.59
-3.45
(-10.14%)
USD |
NASDAQ |
Oct 30, 16:00
30.10
-0.49
(-1.60%)
After-Hours: 20:00
Alamar Biosciences Free Cash Flow : -63.24M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -63.24M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Personalis, Inc. | -100.98M |
| 10X Genomics, Inc. | 121.44M |
| Champions Oncology, Inc. | -6.137M |
| Medpace Holdings, Inc. | 667.63M |
| Avantor, Inc. | 439.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.32M |
| Cash from Investing (Quarterly) | -120.80M |
| Cash from Financing (Quarterly) | 201.84M |
| Free Cash Flow Per Share (Quarterly) | -0.2172 |
| Free Cash Flow to Equity (Quarterly) | 274.07M |
| Free Cash Flow to Firm (Quarterly) | -14.85M |
| Free Cash Flow Yield | -2.98% |